Candriam S.C.A. Nevro Corp Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$30.17 - $41.11 $189,527 - $258,253	-6,282 Reduced 29.52%	14,996 $542,000
Q4 2022 Feb 13, 2023	SELL	$36.43 - $49.4 $8,160 - $11,065	-224 Reduced 1.04%	21,278 $842,000
Q3 2022 Nov 10, 2022	BUY	$40.66 - $53.03 $874,271 - $1.14 Million	21,502 New	21,502 $1 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.